[Cite as http://purl.org/au-research/grants/nhmrc/1078893]
Dr Bryan Day
Brief description High-grade glioma (HGG) is the most common adult brain cancer; current treatments have increased survival times by months only. Our studies have shown brain cancer specific expression of a family of cell surface proteins called Eph receptors. Furthermore we have shown targeting these receptors with Eph antibodies leads to a significant reduction in brain cancer tumour growth. We now propose to test targeting these receptors in combination to achieve greater responses with minimal side effects.
Funding Amount $AUD 612,860.30
Funding Scheme Project Grants
New Investigator Grant